Belladerma Center Medical Skin Care is categorized under Beauty Salons in La Jolla, CA and active since 2002.
Belladerma Center Medical Skin Care was established in 2002, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Beauty Salons business, which does work in the B2C market, and is classified as a Beauty Salons, under code number 812112 by the NAICS.
If you are seeking more information, feel free to contact Sarah Vanhuizum at the company’s single location by writing to 9900 Genesee Avenue # B, La Jolla, California CA 92037 or by phoning (858) 453-8484. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Belladerma Center Medical Skin Care |
| Contact Person: | Sarah Vanhuizum |
| Address: | 9900 Genesee Avenue # B, La Jolla, California 92037 |
| Phone Number: | (858) 453-8484 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Beauty Salons |
| SIC Code: | 7231 |
| NAICS Code: | 812112 |
| Share This Business: |
Belladerma Center Medical Skin Care was started in 2002 to provide professional Beauty Salons under the SIC code 7231 and NAICS code 812112. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Sarah Vanhuizum for inquiries that concern Belladerma Center Medical Skin Care by calling the company number (858) 453-8484, as your correspondence is most welcome. Additionally, the physical location of the single location of Belladerma Center Medical Skin Care can be found at the coordinates 32.885122,-117.222892 as well as the street address 9900 Genesee Avenue # B in La Jolla, California 92037.
For its online presence, you may visit Belladerma Center Medical Skin Care’s website at and engage with its social media outlets through on Twitter and on Facebook.